58 related articles for article (PubMed ID: 31409344)
21. Diagnostic utility of telomere length testing in a hospital-based setting.
Alder JK; Hanumanthu VS; Strong MA; DeZern AE; Stanley SE; Takemoto CM; Danilova L; Applegate CD; Bolton SG; Mohr DW; Brodsky RA; Casella JF; Greider CW; Jackson JB; Armanios M
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2358-E2365. PubMed ID: 29463756
[TBL] [Abstract][Full Text] [Related]
22. The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Wolff F; Leisch M; Greil R; Risch A; Pleyer L
Cell Commun Signal; 2017 Mar; 15(1):13. PubMed ID: 28359286
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.
Borie R; Tabèze L; Thabut G; Nunes H; Cottin V; Marchand-Adam S; Prevot G; Tazi A; Cadranel J; Mal H; Wemeau-Stervinou L; Bergeron Lafaurie A; Israel-Biet D; Picard C; Reynaud Gaubert M; Jouneau S; Naccache JM; Mankikian J; Ménard C; Cordier JF; Valeyre D; Reocreux M; Grandchamp B; Revy P; Kannengiesser C; Crestani B
Eur Respir J; 2016 Dec; 48(6):1721-1731. PubMed ID: 27836952
[TBL] [Abstract][Full Text] [Related]
24. Aging and Pulmonary Fibrosis.
Selman M; Buendía-Roldán I; Pardo A
Rev Invest Clin; 2016; 68(2):75-83. PubMed ID: 27103043
[TBL] [Abstract][Full Text] [Related]
25. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
[TBL] [Abstract][Full Text] [Related]
26. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.
Kannengiesser C; Borie R; Ménard C; Réocreux M; Nitschké P; Gazal S; Mal H; Taillé C; Cadranel J; Nunes H; Valeyre D; Cordier JF; Callebaut I; Boileau C; Cottin V; Grandchamp B; Revy P; Crestani B
Eur Respir J; 2015 Aug; 46(2):474-85. PubMed ID: 26022962
[TBL] [Abstract][Full Text] [Related]
28. Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.
Borie R; Kannengiesser C; Hirschi S; Le Pavec J; Mal H; Bergot E; Jouneau S; Naccache JM; Revy P; Boutboul D; Peffault de la Tour R; Wemeau-Stervinou L; Philit F; Cordier JF; Thabut G; Crestani B; Cottin V;
J Heart Lung Transplant; 2015 Apr; 34(4):538-46. PubMed ID: 25612863
[TBL] [Abstract][Full Text] [Related]
29. Familial pulmonary fibrosis.
Borie R; Kannengiesser C; Nathan N; Tabèze L; Pradère P; Crestani B
Rev Mal Respir; 2015 Apr; 32(4):413-34. PubMed ID: 25596800
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.
Visconte V; Tiu RV; Rogers HJ
Blood Res; 2014 Dec; 49(4):216-27. PubMed ID: 25548754
[TBL] [Abstract][Full Text] [Related]
31. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome.
Ritchie EK
Clin Interv Aging; 2012; 7():165-73. PubMed ID: 22791989
[TBL] [Abstract][Full Text] [Related]
33. Infections in myelodysplastic syndromes.
Toma A; Fenaux P; Dreyfus F; Cordonnier C
Haematologica; 2012 Oct; 97(10):1459-70. PubMed ID: 22733024
[TBL] [Abstract][Full Text] [Related]
34. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Raghu G; Collard HR; Egan JJ; Martinez FJ; Behr J; Brown KK; Colby TV; Cordier JF; Flaherty KR; Lasky JA; Lynch DA; Ryu JH; Swigris JJ; Wells AU; Ancochea J; Bouros D; Carvalho C; Costabel U; Ebina M; Hansell DM; Johkoh T; Kim DS; King TE; Kondoh Y; Myers J; Müller NL; Nicholson AG; Richeldi L; Selman M; Dudden RF; Griss BS; Protzko SL; Schünemann HJ;
Am J Respir Crit Care Med; 2011 Mar; 183(6):788-824. PubMed ID: 21471066
[TBL] [Abstract][Full Text] [Related]
35. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.
Parry EM; Alder JK; Qi X; Chen JJ; Armanios M
Blood; 2011 May; 117(21):5607-11. PubMed ID: 21436073
[TBL] [Abstract][Full Text] [Related]
36. Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.
Papiris SA; Manali ED; Kolilekas L; Kagouridis K; Triantafillidou C; Tsangaris I; Roussos C
Crit Care; 2010; 14(6):246. PubMed ID: 21235829
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison.
Papiris SA; Tsirigotis P; Kannengiesser C; Kolilekas L; Gkirkas K; Papaioannou AI; Revy P; Giouleka P; Papadaki G; Kagouridis K; Pappa V; Borie R; Boileau C; Bouros D; Crestani B; Manali ED
Respir Res; 2019 Aug; 20(1):182. PubMed ID: 31409344
[TBL] [Abstract][Full Text] [Related]
38. [Telomeres and lung].
Guérin C; Crestani B; Dupin C; Kawano-Dourado L; Ba I; Kannengiesser C; Borie R
Rev Mal Respir; 2022 Sep; 39(7):595-606. PubMed ID: 35715316
[TBL] [Abstract][Full Text] [Related]
39. Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis.
Spagnolo P; Wuyts W
Curr Opin Pulm Med; 2017 Sep; 23(5):411-417. PubMed ID: 28582317
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic pulmonary fibrosis: phenotypes and comorbidities.
Fell CD
Clin Chest Med; 2012 Mar; 33(1):51-7. PubMed ID: 22365245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
